|Articles|April 1, 2003
- Pharmaceutical Executive-04-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 23 years ago
In the Eye of the Stormover 23 years ago
Pharma WANTS YOUover 23 years ago
What They're Not Sayingover 23 years ago
Generic Treatment Claims: Do They Hold Water?over 23 years ago
Generics Battle Heats Upover 23 years ago
HBA's 2003 Woman of the YearAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
5